SK
Sharandeep Kaur
About Sharandeep Kaur
Data last updated:
Sharandeep Kaur is a Director at Orange Biotech Private Limited (since 2014) and Director at Saffron Medicare Private Limited (since 2010). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹8.02 Cr; the largest is Orange Biotech Private Limited at ₹8.01 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Feb 2014 | 2011 | ₹8.01 Cr (FY 2025) | Active | |
| Director | 30 Jul 2010 | 2008 | ₹1.1 Lakh (FY 2024) | Active |
Board colleagues of Sharandeep Kaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Inder Jeet Singh | 02355583 | Orange Biotech Private Limited , Saffron Medicare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sharandeep Kaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sharandeep Kaur
Sharandeep Kaur currently holds 2 directorships: Orange Biotech Private Limited (Director, since 14 Feb 2014, revenue ₹8.01 Cr (FY 2025)); Saffron Medicare Private Limited (Director, since 30 Jul 2010, revenue ₹1.1 Lakh (FY 2024)).
Sharandeep Kaur was first appointed on 30 Jul 2010 as Director at Saffron Medicare Private Limited. The most recent appointment on record is 14 Feb 2014 at Orange Biotech Private Limited.
The 2 current companies of Sharandeep Kaur that report revenue have a combined latest revenue of ₹8.02 Cr: Orange Biotech Private Limited ₹8.01 Cr (FY 2025); Saffron Medicare Private Limited ₹1.1 Lakh (FY 2024).
The current boards of Sharandeep Kaur's companies include Inder Jeet Singh (Orange Biotech Private Limited).